Clinical trial
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
NCT00109798 · The Methodist Hospital Research Institute, Other · Withdrawn
Key facts
| NCT number | NCT00109798 |
|---|---|
| Title | Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma |
| Official title | Phase II Trial of Salvage Chemotherapy With Temozolomide in Combination With Topotecan for Primary CNS Lymphoma |
| Lead sponsor | The Methodist Hospital Research Institute, Other |
| Collaborators | Baylor College of Medicine |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Central Nervous System Tumors, Lymphoma |
| Intervention type | Drug |
| Interventions | temozolomide, topotecan hydrochloride |
| Enrollment | 0 |
| Start date | Mar 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | May 4, 2005 |
| Last update posted | Sep 19, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: